Kucukguven Arda, Galandarova Aysuna, Bitik Ozan
Department of Plastic, Reconstructive and Aesthetic Surgery, Ankara Training and Research Hospital, University of Health Sciences, Ankara, Turkey.
Faculty of Medicine Ankara, Yildirim Beyazid University, Ankara, Turkey.
Aesthetic Plast Surg. 2023 Feb;47(1):144-155. doi: 10.1007/s00266-022-02894-8. Epub 2022 May 9.
Early relapse is an adverse outcome of facelift surgery. The rate of early relapse is an indirect measure of the longevity and efficacy of facelift techniques. However, early relapse after facelift is ill-defined, under-evaluated, and under-reported, and literature data on the subject are dispersed. In this systematic review, we aimed to analyze facelift studies using relapse-related outcomes (RROs). Our secondary aim was to highlight the importance of early relapse as an essential outcome measure.
The study design was a systematic review of the English literature and meta-analysis of RROs after facelift surgery. RROs that occurred within the first 2 years after surgery were considered "early". Performance, analysis, and reporting were performed in accordance with the PRISMA guidelines. The systematic search was conducted using the PubMed database as of February 2020. Initial screening was performed using the keywords "facelift", "rhytidectomy", "surgical rejuvenation", "face lift", "rhytidoplasty", and "facial rejuvenation". Articles were excluded by using a set of inclusion and exclusion criteria.
RROs were reported only in 4.4% (19/433) of the papers that underwent full-text review. The frequency of RROs ranged between 0.2 and 50% among facelift papers. The weighted median rate of RROs after facelift surgery was found to be 2.4% in the meta-analysis.
Future research on preventive measures will be successful upon acknowledgment of the actual prevalence of this problem. Consensus on its definition and objective criteria for its diagnosis are required for further progress.
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
早期复发是面部提升手术的不良后果。早期复发率是面部提升技术持久性和有效性的间接指标。然而,面部提升术后的早期复发定义不明确、评估不足且报告不充分,关于该主题的文献数据分散。在本系统评价中,我们旨在分析使用复发相关结局(RROs)的面部提升研究。我们的次要目的是强调早期复发作为重要结局指标的重要性。
研究设计为对面部提升手术后RROs的英文文献进行系统评价和荟萃分析。手术后2年内发生的RROs被视为“早期”。按照PRISMA指南进行数据收集、分析和报告。截至2020年2月,使用PubMed数据库进行系统检索。初始筛选使用关键词“面部提升”、“除皱术”、“手术年轻化”、“面部提拉”、“除皱整形术”和“面部年轻化”。根据一组纳入和排除标准排除文章。
在接受全文审查的论文中,仅4.4%(19/433)报告了RROs。在面部提升论文中,RROs的发生率在0.2%至50%之间。荟萃分析发现,面部提升手术后RROs的加权中位数率为2.4%。
在认识到该问题的实际患病率后,未来关于预防措施的研究将取得成功。需要就其定义和诊断的客观标准达成共识,以取得进一步进展。
证据水平III:本杂志要求作者为每篇文章指定证据水平。有关这些循证医学评级的完整描述,请参阅目录或作者在线指南www.springer.com/00266 。